Inscription Capital’s Labcorp LH Stock Holding History

Inscription Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$519K	Sell	1,945 -33	-2%	-$8.94K	0.05%	352
2025 Q4	$496K	Buy	+1,978	New	+$525K	0.05%	363

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Inscription Capital's LH Position: Q1 2026 in Review

Inscription Capital reduced its Labcorp (LH) stake by 1.7% in Q1 2026, selling an estimated $8.94K and leaving 1,945 shares worth $519K. The position accounts for 0.05% of the portfolio, ranked #352.

Inscription Capital first reported a position in LH in Q4 2025 and has held it in 2 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Inscription Capital held 1,945 shares of Labcorp worth $519K as of Q1 2026.
Inscription Capital sold 33 Labcorp shares in Q1 2026, an estimated $8.94K.
Labcorp made up 0.05% of Inscription Capital's portfolio in Q1 2026, its #352 holding.
Inscription Capital first reported a position in Labcorp in Q4 2025 and has held it in 2 quarters since.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.